Work

Serum RNASE3 and TREM2 biomarker set predicts clinical response to benralizumab in nasal polyps

Year: 2024

Type: conference-abstract

DOI: 10.1183/13993003.congress-2024.pa835

Authors: Zala Jevnikar Rojnik, Mathias Cardner, Giovanna De Palo, Hoda Sharifian, Lisa Öberg, David Cohen, Sofia Necander, Maria Jison, Viktoria Werkström, Chris Chamberlain, Adam Platt, Daniel Muthas, Christopher Mccrae

Institutions: AstraZeneca (Sweden), AstraZeneca (United Kingdom), AstraZeneca (United States)

Language: English

Topic: Sinusitis and nasal conditions

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404101681

Cites:

Cited by:

Related to: 10